首页> 外文期刊>Cardiovascular therapeutics >What should medical practitioners know about the role of alternative medicines in cardiovascular disease management?
【24h】

What should medical practitioners know about the role of alternative medicines in cardiovascular disease management?

机译:从业人员应了解替代药物在心血管疾病管理中的作用?

获取原文
获取原文并翻译 | 示例
           

摘要

Alternative medications as a term call up many different meanings, significance, and perceptions to various medical practitioners. Some are good; others are bad. A wide range of alternative medications with relevance or connection to cardiovascular (CV) disease have been considered. While many are worthless, others have definite benefit, and at least one, chelation therapy, is associated with definite harm, significant risk, no benefit, and enrichment of the practitioners who prescribe it. The issues concerning alternative therapies will likely never be studied with randomized clinical trials due to the lack of a profit motive on the part of pharmaceutical companies--only rarely do other institutions, such as the National Institutes of Health, support medicinal studies. Basic knowledge of alternative therapies is essential for the CV specialist and other practicing physicians and other practitioners, since at least a few of their patients will take these medications regardless of medical advice. The result is that a number of these alternative medications will then interact with conventional CV medications, many times unfavorably.
机译:替代药物作为一个术语,对各种医疗从业人员具有许多不同的含义,意义和看法。有些很好;其他人不好。已经考虑了与心血管疾病(CV)相关或相关的多种替代药物。尽管许多人一文不值,但其他人则具有一定的益处,至少一种螯合疗法与确定的危害,重大风险,无益以及开处方者的丰富化有关。由于制药公司缺乏获利动机,因此关于替代疗法的问题可能永远不会通过随机临床试验进行研究,而美国国立卫生研究院等其他机构很少支持医学研究。替代疗法的基本知识对于CV专家,其他执业医师和其他执业者至关重要,因为无论他们的医疗建议如何,至少有一些患者会服用这些药物。结果是,许多这些替代药物将与传统的CV药物相互作用,很多时候是不利的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号